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ABSTRACT
Background Ventilatory support has benefits
including prolonging survival for respiratory
failure in motor neurone disease (MND). At some
point some patients may wish to stop the
intervention. The National Institute of Health and
Care Excellence (NICE) guidance recommends
research is needed on ventilation withdrawal.
There is little literature focusing on the issues
doctors encounter when withdrawing ventilation
at the request of a patient.
Aim To identify and explore with doctors the
ethical and legal issues that they had
encountered in the withdrawal of ventilation at
the request of a patient with MND.
Method A retrospective thematic analysis of
interviews of 24 doctors (including palliative care,
respiratory, neurology and general practice)
regarding their experiences with withdrawal of
ventilation support from patients with MND.
Results Respondents found withdrawal of
ventilation at the request of patients with MND
to pose legal, ethical and moral challenges in five
themes: ethical and legal rights to withdrawal
from treatment; discussions with family;
discussions with colleagues; experiences of legal
advice; issues contributing to ethical complexity.
Though clear about the legality of withdrawal of
treatment in theory, the practice led to ethical
and moral uncertainty and mixed feelings. Many
respondents had experienced negative reactions
from other healthcare professionals when these
colleagues were unclear of the distinction
between palliation of symptoms, withdrawal of
treatment and assisted death.
Conclusions Legal, ethical and practical
guidance is needed for professionals who
support a patient with MND who wishes to
withdraw from ventilation. Open discussion of
the ethical challenges is needed as well as
education and support for professionals.
BACKGROUND
Motor neurone disease (MND) is a pro-
gressive neurological condition which pri-
marily affects motor neurons leading to
skeletal muscle weakness including
respiratory muscles. Most deaths in
MND are due to respiratory failure.
Using non-invasive ventilation (NIV)
support can improve quality of life,
symptoms and survival1 2 and UK guid-
ance from the National Institute of
Health and Care Excellence (NICE) sup-
ports its use.3 NIV can very effectively
support ventilation, often for many
months.4 A few patients may choose ven-
tilation via tracheostomy (TV) if NIV
fails. In the UK the use of NIV has
increased over the past 10 years.5 The
number of patients on TV is unknown.
Neurological deterioration is relentless
for patients despite ventilation and
patients may eventually reach a point at
which they cannot move or communicate
(‘locked in’).6 Many patients also develop
cognitive change which can affect their
ability to make decisions.7
Although getting used to NIV can be
problematic8 with perseverance over a
few weeks many patients report an
improved quality of life.1 9 Longitudinal
studies of patient experience through the
full course of their illness are lacking but
a recent study of five patients who had
used NIV for more than 12 months has
shown that even for those that adapt well
to using NIV and are positive about its
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value for them, the commonest negative psychological
experience was related to dependence.10
It appears from our collective clinical experience
that the majority of patients using NIV in the UK die
while still using it. However, some patients who are
dependent on NIV, and some on TV, will wish to stop
because they can no longer tolerate it or because of
deterioration in other factors impacting on their
quality of life. Some may make a written statement
with respect to withdrawal in advance of their losing
the ability to communicate or other reason for loss of
capacity.11
We have previously reported on our questionnaire
study with doctors in palliative medicine in which we
gained an overview of the magnitude and frequency
of the emotional, practical and ethical issues that may
arise in this context.12 We have explored these issues
in more depth with this qualitative study. This paper
reports on one theme which has emerged from the
data: the ethical and legal challenges experienced by
doctors who have withdrawn ventilation at the request
of a patient.
METHODS
This was a retrospective qualitative interview study.
Doctors were asked to talk about the most recent and
other most notable patients with whom, at the request
of the patient with MND, they had withdrawn venti-
lation. A topic guide, developed from the scoping
study12 was utilised flexibly to explore each doctor’s
experiences in detail.
Participants and data collection
Doctors, across England, Wales and Scotland, who
had withdrawn ventilation at the request of a patient
with MND within the past 5 years, were invited to
participate in a one to one interview in person or by
telephone as they preferred.
A multifaceted email recruitment strategy was
employed to approach participants:
Directly to doctors
▸ Members of the Association for Palliative Medicine of
Great Britain and Ireland (APM) who had responded to
the scoping study indicating their willingness to
participate.
▸ APM members of the advanced neurological disease spe-
cialist interest forum.
Indirectly via a network
▸ MND Clinical Studies Group within the Dementia and
Neurodegenerative Diseases (DeNDroN) research
network for England and Wales.
▸ Regional Care Advisors for the Motor Neuron Disease
Association who then contacted doctors they knew had
been involved with such patients.
▸ Motor Neuron Disease Regional Care Centre clinical
directors and coordinators.
▸ Lane Fox Unit Guy’s and Thomas’, Papworth and Kings
College Hospitals specialist respiratory teams leads.
▸ British Thoracic Society home ventilation-UK group.
Everyone contacted by email was asked to pass this
on to other doctors who they thought might be
interested.
R&D approval was sought for those who contacted
the principle investigator (CF) to discuss participation
and subsequently full participant information was
shared. Consent was taken in person before
face-to-face interviews or by phone with subsequent
email of written consent.
Purposive sampling was used to achieve the broad-
est diversity of medical specialties. This resulted in
three palliative care doctors not being interviewed but
all other volunteers being recruited.
Data analysis
The interviews were audiorecorded and transcribed
and interviewers (ER and KP) maintained reflexive
diaries. Data from transcripts were analysed by con-
stant comparison based on grounded theory to iden-
tify themes.13 14 Open coding: (ER and KP)
summarised the ways that participants talked about
the issues and processes that mattered. These codes
were progressively focused into broader categories,
forming the initial coding frame, further shaped by
Steering Group discussion. The coding frame was sys-
tematically applied by KP and ER, discussing situa-
tions of uncertainty of coding and using NVivo V.9
software, and continuously developed in response to
new information.
The purpose of analysis was to illustrate the breadth
of experience, opinions, views and practices of the
study participants, identify challenges and ways to
improve the experiences of all those involved in venti-
lation withdrawal. The themes emerging from the
interviews relating to the ethics and legality of ventila-
tion withdrawal are illustrated in the table 1.
No new themes were elicited after 15 interviews but
each interview and each patient discussed within an
interview conveyed a uniqueness of context and
nuance.
Ethical concerns
The study was approved by the East Midlands Derby
Research Ethics Committee reference 11/EM/0131.
All participants were provided with participant infor-
mation sheet that explained their involvement in the
study.
FINDINGS
Twenty four doctors (15 palliative medicine labelled
A1-A15, 1 neurologist labelled B1, 4 anaesthetist/
respiratory labelled C1-4 and 4 GPs labelled D1-4)
were interviewed, 5 by telephone and 19 face to face.
Sixteen had withdrawn NIV only, five had withdrawn
TV only, and three had withdrawn both NIV and TV.
Nine respondents had been involved with more than
one patient.
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The setting for withdrawal included home (the most
common for TV), hospice (the most common for
NIV), acute hospital, community hospital and one
care home. Such events were rare but extraordinarily
memorable with explicit detail of aspects recalled
from several years previously. The emotionality and
the tensions of the situation were especially vivid.
Discussions of ethics, morals and legality went hand
in hand. It was felt that the ethics were complex:
while ethical theory can be clear, applying ethics to a
clinical situation was not straightforward and was for
some professionally and personally burdensome.
A11 … the discussion around the ethics, it’s messy.
Ethics is messy by the bed side, that’s the thing. … I’m
absolutely clear on the ethics of it, there’s no doubt
that was the right thing to do. It was just at the time
and in that slightly surreal sort of circumstances, it just
felt very, very strange and uncomfortable.
The patient has a legal right to withdrawal from
treatment
The patient’s ethical and legal right to refuse or with-
draw from treatment even when this may hasten their
death was affirmed by all participants. Continuation of
treatment when a patient did not wish it was consid-
ered wrong. However, doctors reflected on the poten-
tial that there was to override this right where the
patient still had considerable functional abilities; the
patient’s prime wish was to cease living; or because it
was much easier not to carry out the patient’s wishes
than it was to withdraw ventilation (box 1).
Doctors used a clear framework to decide whether
each individual case was ethical and legal in practice.
This was that withdrawal from treatment was a sus-
tained wish of the patient; that the patient had cap-
acity and was not depressed; that the patient had
made an informed choice and was not influenced
unduly by others; and the patient was aware of the
consequences of withdrawal. Doctors went to consid-
erable lengths to establish these features with patients.
Working with this framework could be very challen-
ging due to significant difficulties in communication
caused by MND (box 2).
Discussions with family
A key part of the doctor’s work was discussing and
explaining the legal and ethical context with patients
Box 1 Reflections on the patient’s right to have
ventilation withdrawn
A05: … and if a patient has an intervention that they do
not want and even if they’re asking for removal of it and
that’s going to bring life to an end, they have the abso-
lute right to do that.
A09: … you need to be careful not to bring your own
resistance because this is unusual or difficult. It has an
impact. In a sense it’s easier to do nothing than it is to
say well we’ll withdraw it.
A17: … if the patient is clearly saying and they are
autonomous and competent to say ‘I want my Nippy
removed’, then we are following their wishes. If they
want to do that because they want their life to end, well
clearly they probably do want their life to end, because
once you tell them well if we stop the Nippy you’ll die,
then clearly that’s what they want. So in a way yes
maybe we are fulfilling their wishes to die. You end up
talking yourself in circles don’t you, but that’s OK
because they can refuse life prolonging treatment …. So
I think it feels slightly uncomfortable but I still think it’s
the right thing to do.
B03: The ethical issue actually is refusing to do it, that
would be an act of great wickedness and cruelty.
Box 2 The complexity of assessment of wishes and
capacity
A04: Communication with him was very difficult because
by this stage he could just move his eyes left and right so
there were quite a lot of yes/no questions. We used the
alphabet board as well. But it was very clear that he
wanted to have it removed … he didn’t feel depressed, he
just felt that his quality of life had deteriorated as his illness
had progressed and he wanted to be allowed to die natur-
ally from that…. I was very happy that his wish was clear
and sustained and he had capacity.
A16: I think my worry was she’d become incredibly
depressed and had therefore decided to stop it, but once
we’d established that, I felt perfectly comfortable.
Table 1 Legal and ethical themes emerging from interviews
with doctors
Main theme Subthemes
Theoretical knowledge of
ethics and the law
Is withdrawal ethical and legal
Is it unethical or illegal not to withdraw
Under what circumstances is it legal and
ethical to withdraw
What if patient is not close to death
Ethical and legal practice Experience and knowledge
Discussions of ethics and the law with
colleagues, patients and families,
including disagreements.
Palliation of symptoms—what is legal
External scrutiny, the need to document
practice and work in teams for legal
security
Protecting the family ethically, morally and
legally
Does withdrawal feel ethical
and moral
Felt right
Felt uncomfortable or wrong
Fear of misinterpretation as assisted death
Ethical and moral burden
Ethical and legal
recommendations
Need for legal and ethical guidance
Need for professional education
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and families. Respondents felt a need to gain agree-
ment from and within the family because it felt
‘easier’ to enact decisions based on consensus. These
discussions were also to mitigate the risk of legal
action or exposure in the media. Such conversations
could be difficult with some families wanting to
discuss other issues such as euthanasia and physician
assisted suicide (box 3).
Discussions with colleagues and coping with the differing
views of colleagues
All respondents talked about the importance of open
discussion about ethics and legality with colleagues.
This could require a considerable amount of time and
effort. The circumstances of every case required
exploration and the rationale needed to be transpar-
ent, articulating the legal and ethical framework and
demonstrating that the necessary criteria were in place
(box 4). Fostering consensus and listening to dissent
were important strategies and enhanced the doctor’s
own ethical learning.
Several participants experienced disagreements with
healthcare colleagues who considered ventilation
withdrawal to be ethically or legally unacceptable and
different from withdrawal of other treatments. Some
colleagues saw it as assisted suicide. Doctors perceived
that the elements of this concern were: the withdrawal
of life sustaining treatment was seen as the cause of
death for the patient (rather than the MND); that the
drugs used to manage symptoms were perceived as
shortening life; that the close timing of stopping treat-
ment and death occurring was perceived as causality;
differing opinion on validity of advance decisions
(box 5).
This caused stress and fear for some of the profes-
sionals involved, and in more than one case a court
hearing. This professional reluctance sometimes had
an influence on choice of setting for patients and
required consideration of how to handle staff discom-
fort or refusal to take part on the grounds of con-
science. Occasionally the patient did not have their
request fulfilled. Wider discussion and education
among professionals to clarify the legal and ethical
position of withdrawal of ventilation was felt to be
needed.
Most respondents had discussed the situation with a
considerable number of peers, and palliative medicine
consultants often had a key role in articulating the
ethico-legal framework. The need for greater support
for doctors who are responsible for the care of the
patient was highlighted (box 6). First to discuss and
clarify the ethical and legal issues; second to give pro-
fessional backup should questions be raised after the
withdrawal; and third to share the emotional impact.
Because of the rarity of the situation and the lack of
expertise in ethico-legal matters some thought that
formal affirmation of a clinical ethics committee
would be very valuable and the two respondents who
had experience of this had found it very positive.
Experiences of legal advice
The majority of doctors, sure of the legality of the
care, did not seek legal advice or guidance. Some did
consult with their personal medico-legal advisors or
Trust legal department and many received clear
Box 3 The complexity of discussions with family
A16: I think some of them found it more difficult than
others and I think managing the expectations of 4 adults
with different views, that was quite difficult, and some
of them were very, just emotional about the ethics of it
and whether it was the right thing.
B03: Her partner, it was much more complicated. I met
him on a number of occasions with her permission and it
became clear that his agenda was a little different and
was very much about controlling things, including talking
about actively ending her life in all sorts of ways. He
wanted to discuss euthanasia and all this sort of stuff, so
it was challenging professionally to do that.
A16: Probably the most challenging thing of that inter-
vention was the discussions with the family, because
they’d got themselves in a real tangle about whether
taking the mask off was shortening her life in any way
Box 4 Educating colleagues and facilitating safe
team working
A04: I wanted to get all the nursing staff together
because I didn’t want any of them to feel that what
we’d done was, well, something it wasn’t and wanted to
make sure that they were all happy with what we were
doing and give them an opportunity to ask any
questions.
A07: Part of making it, sort of, almost emotionally and
psychologically safe for the staff and for me as being the
consultant was to actually get some agreement quite
early on in terms of the framework of ethics and law
that we’re working under.
D10: It’s reinforced for me the value of teamwork where
there are difficult ethical issues to tackle. The value of
sharing opinions, not just with other doctors but with
other professionals, family, lay people. That is what
makes an ethical society I think is the shared values.
A13: I don’t think I was asking colleagues or discussing
it with colleagues because I wanted their approval and
to make sure that they thought it was the right thing to
do, because I knew it was the right thing to do, I didn’t
have any doubts about that at all, but it was just making
sure that their views were consistent with mine…
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advice. However, some respondents found this
contact promoted an even greater sense of vulnerabil-
ity and did not enhance patient care. Some were
advised not to be involved in the withdrawal (box 7).
Issues contributing to ethical complexity
Doctors reflected on the issues which contributed to
the ethical complexity of the situation (box 8).
Cause and effect
Because of the direct link between removal of ventila-
tion and death and because of the closeness in time of
action and effect, respondents felt that the patient
died because of something they did. Doctors had to
reconcile their intensive involvement in the patient’s
care with a sense of responsibility or causation of
dying.
Planning when to withdraw treatment (and to die)
A consequence of the immediacy of death subsequent
to withdrawal meant that patients, families and profes-
sionals were aware that the plan for withdrawal was
also setting the time for death. This was unfamiliar
and the aspect most in tension with practices aimed
directly at ending life. An added ethical complexity
acknowledged by doctors was that some patients were
explicitly asking for the treatment to be stopped
because they did not want to continue to live or face
further loss of ability.
Breathing is fundamental
It was thought that removal of ventilation may feel
ethically different than removal of other treatments
due to the fundamental nature of breathing to stay
alive.
Rarity
The relative rarity of the event itself, and that this
involved the very unusual situation for most doctors
of stopping a machine, was reflected on by respon-
dents. That a patient requested it to be stopped con-
trasted with most other circumstances where machines
are stopped because the clinicians decided that the
intervention was no longer helpful.
A conscious patient
Withdrawal of treatment, leading to death, from a
patient who was alert, often able to communicate and
who had no other vital organ disease making them
unwell caused considerable soul searching.
Box 5 Working with professional disagreement
B03: What killed that patient was her disease not a mid-
azolam injection. So I went to talk to them and we
talked it all through and I don’t think I ever came away
feeling I totally understood what their problem was. It
simply was out of their comfort zone because they have
a certain view of what they do and this seemed to be
just at the boundary, it seemed to be to them a little bit
more active than they normally do.
A14: A lot of it felt like education rather than a really
deep ethical debate about the right to life.
A02: I think the difficulty is if you integrally believe
something, like I intrinsically feel that it’s the disease
and not your action that’s making them die, if they think
that action is what equals you killing them or them
dying, then that intrinsic feeling that you have is very dif-
ficult to shift that, even through rational thought and
discussion.
A11 They just didn’t feel they were geared up to be
dealing with that sort of ethical issue. Everyone I think in
it was worried about what kind of death he’d have. The
pressure was, this would be far better done at the
hospice if he wants this done. But he didn’t want that,
he wanted to be at home.
A04 The plan was for him to come in and have ventila-
tion withdrawal and a lot of the nurses were very against
that. They were concerned that it was euthanasia. In the
end, the patient actually died before the ventilation was
withdrawn.
Box 6 The need for more professional support for
the doctor leading the patient’s care
A09: I suppose my feeling was I didn’t want one profes-
sional to be left being the one who did it. If you’re one
member of staff and you are the one switching off the
machine, then I think that’s difficult.
A04: And I think that was a huge part of my role was
supporting people to do that (withdrawal of ventilation)
and saying ‘This is O.K, This is the right thing to do’.
D06: I spoke with a Palliative Medicine consultant on a
number of occasions about it and we discussed the legal
framework around it; that we were withdrawing a life
preserving treatment if you like rather than actively
ending somebody’s life as such.
D10: But actually it was just her (Palliative Medicine con-
sultant) and me I think and his wife round the bedside
that time and I’ve got to say that was really helpful. And
she said -, she made the ethics clear, that it’s his deci-
sion to remove the mask and he knows the
consequences.
A13 He needed reassurance from me a fellow doctor; he
needed reassurance from his clinical partners and he
needed reassurance from his defence union that what we
were doing was within the bounds of legality.
A15: If you have somebody else who’s done it and been
through it; how much did you give and what was the
result. That sort of support I think would always be
helpful.
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Palliating symptoms and relieving suffering
Respondents had experienced anxieties about the
ethics related to the use of medication as the ventila-
tion was withdrawn. Some felt that as the patient’s
death was imminent, the amount of medication was
irrelevant as long as the patient experienced no suffer-
ing. Others felt concerned that they were not seen to
hasten the patient’s death with medication.
DISCUSSION
Our research is the first to explore in depth the
experiences of doctors involved in the withdrawal of
ventilation at the request of a patient with MND. This
is a rare event but the work draws on interviews with
24 doctors with more than 30 patients. All narratives
described huge complexity in the reality of applying
law and ethics to real life socioclinical contexts.
The right of a patient who has capacity for the deci-
sion to refuse treatment and for symptoms of with-
drawal to be managed effectively is clear in case law15
and in the medical code of conduct in the UK.16 All
our participants understood these facts and their role
was often to help both families and colleagues under-
stand them too. Most often this led to consensus. In
some instances, however, people’s individual perspec-
tives were not reconcilable. These tensions in end of
life decision-making are echoed in other work which
explores decision-making17 18 but no work to our
Box 7 Experiences of legal advice
A11 There’d been all sorts of concerns about well ‘do we
need to tell the coroner in advance of this?’, ‘do we
need to inform our medical defence organisation in
advance of this?’ and a lot of angst about the legality of
it. And the advice had been from the defence organisa-
tion get on and do it.
A14: I rang the defence organisation sort of saying,
they’re not particularly palliative so they were saying ‘oh
you might want to get a second opinion’. So I thought
I’d better had in case this daughter went to the Police.
—and I did feel bad because I did drag it out another
24 h.
C20: The defence organisation was useless actually. I
know more about the ethics of this than they did.
D10. The defence organisation said that it would be
unlawful to remove the mask purely for the purpose of
hastening his death. And that was worrying because,
well, effectively, we were going to remove the mask and
we knew that the consequences were going to be that
he’d die of natural causes. And so that was really a
rather unhelpful way of putting it. The second point they
made was that it was not unlawful to respect his refusal
to accept treatment, providing he is of sound mind. And
then they said it would be prudent to involve a palliative
care consultant and a neurologist to explore alternatives.
And they made a great thing of the fact that how do you
know he’s got MND? How do you know that there’s no
cure? Hadn’t you better keep searching for a cure? ….
D18: The family come to me because I’m their GP. They
ring me up and say he wants his nippy removed. I get
people like him (defence organisation) telling me ‘You’re
not qualified, you shouldn’t be involved.’ and I get other
people speaking to me saying ‘You’re his GP, you are
responsible for every element of his care. If you don’t
turn off his nippy and he doesn’t consent to it, you’re
assaulting him.’ I asked the PCT for legal help, I asked
the PCT for a lead and I just got passed round the
houses and it got thrown back in my court. The person
they did say should lead it didn’t step up.
Box 8 The issues identified as promoting ethical
complexity
A08 it feels that one moment you’ve got a patient there
who’s alive and able to do things and have some com-
munication with you about themselves and then it feels
as though through my action, 10 min later they’re dead.
A15 Although it’s withdrawing artificial treatment,
there’s a very clear causal link with turning off the
machine and dying a short while afterwards.
A14: I was setting a time. I was agreeing with the wife
the time at which he would die and eeuurrgh it was hor-
rible, but it wasn’t what we were doing, it was—‘I’ll see
you at 11 and we’ll do it then.’ Of course you’ve got to.
They wanted to be with him. They needed to know when
we were going to do it.
C12: I think it’s harder to stop something, some way of
giving people oxygen or helping them to breathe more
easily unless they’re very very unwell.
A13 people who are on kidney dialysis and that’s a
machine that’s keeping their kidneys going, they elect to
stop having dialysis and they’ll die usually fairly quickly,
usually within days of stopping dialysis. But breathing’s
perhaps a bit more emotional so anything to do with the
heart or breathing might be a bit more emotional for
people.
A16: I think it is different because it’s much more imme-
diate and breathing seems one of those very elemental
things to us.
A08: There’s a strange illusion of, perception of gosh I’m
giving them a drug that’s causing them to die. Even
though rationally one knows that that’s not the case.
C20: The anxieties that people have that they will be
perceived as giving patients drugs to end their lives.
A05: it did feel very strange going back later on with an
intravenous canula for administration of midazolam to
avoid respiratory distress. Even though I knew that we’d
done everything ethically and legally correctly, it just
inevitably conflicts with feelings of euthanasia and
assisted suicide.
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knowledge has previously sought to understand the
experiences of professionals themselves. Gannon has
previously described the impact of consideration of
the request of a patient to withdraw ventilation within
a hospice setting and identified similar themes that
raise ethical tensions within professional hospice
teams.19 LeBon and Fisher reported on withdrawal of
TV on a patient in the community and found that the
legal and ethical distinctions between euthanasia,
assisted suicide and withdrawing active treatment fol-
lowing a request from a competent patient may
remain blurred for many clinicians and require a clear
explanation.20
While it may be thought that advance care planning
offers a way to reduce ethical complexity our findings
have shown that even when patient wishes are fully
articulated and documented the enactment of these
wishes in relation to withdrawing treatment and man-
aging symptoms may not be straightforward.
Because the discomfort and potential impact of the
situation was so great may participants sought further
advice from colleagues, medical defence organisations
and ethics committees. In some cases far from sup-
porting patient care these discussions increased the
complexity and anxiety for professionals and delayed
the response to the patient. This situation is untenable
and the Association for Palliative Medicine has pro-
duced a position statement on this specific area of
care (see online supplementary appendix 1).
The complex ethics in the relatively common scen-
ario of withdrawal of ventilation in intensive care
have been discussed.21 22 Two key features of with-
drawal of ventilation at the request of a patient with
MND make it different. First, it is the patient asking
for it to be stopped, not a decision made on the basis
of the failure of medical treatment. Where similar
situations arise in intensive care this is acknowledged
as increasing ethical (and practical) difficulty.23
Second the patient is conscious and often communi-
cating although some will have lost this function.
Tweeddale has discussed how while explicit direction
by a patient should make care more straightforward,
in practice this may raise tensions professionals may
not be consciously aware of.18
For many of our respondents even though the
ethical and legal arguments had been discussed and
checked and documented, withdrawal of ventilation
still felt uncomfortable. The BBC Radio 4 Inside the
Ethics Committee has helpfully explored the roots for
such ambiguity.24 The extraordinariness of planning a
time for withdrawing a treatment which will closely
be followed by death is a key element of this.
Additionally perhaps, because the clinician is aware
the patients reasoning behind withdrawal of ventila-
tion may be based on the desire to end their lives, the
removal can feel like assisted suicide. In these circum-
stances then, the arguments of some clinicians that it
felt ‘wrong’, even though it is ethically, morally and
legally ‘correct’ has an importance in ensuring care
practice is within the boundaries of Good Medical
Practice.25
Doctors felt that experience, knowledge, open dis-
cussion and documentation were all needed in each
case to ensure the safety of everyone involved, not
least the patient. Experience around withdrawal of
treatment and/or end of life care helped a professional
to understand the ethical and legal issues and feel con-
fident in their practice. It was thought that healthcare
professionals who lacked the relevant experience may
be less likely to understand the ethics and legality of
withdrawal and consider it to be assisted suicide.
Many participants had engaged in protracted discus-
sions with colleagues about whether or not assisting a
patient to withdraw from their ventilation was assisted
death, and some felt that this is an area which requires
debate and specific clarification. There was a great
deal of concern that if other healthcare professionals
could view withdrawal as assisted death, then the
wider public would also lack understanding. It may
not have been that they did not understand the argu-
ments, however, but that to them it felt morally, if not
legally, wrong. A further risk is that patients poten-
tially do not receive the end of life care they wish for
if staff refuse to participate, or that patients cannot
die in their preferred place of death.
CONCLUSION
The experiences of doctors in our study was that the
ethical and legal issues around withdrawal of ventila-
tion at the patient’s request while ostensibly straight-
forward, in practice lead to highly complex
discussions and emotions. This may impact on patient
care. Many professionals need more education and
support including the provision of clear and consistent
advice. This would not only support clinicians but
would also protect patients and their families from
the agonies of indecision and ambiguity.
Robust advance care planning processes which enable
patients to share their choices may help to reduce ambi-
guity but are not a failsafe unless professionals act in
accordance with the legal frameworks underpinning
advance decision-making. The role of Palliative
Medicine doctors is often to help patients, families and
colleagues understand and work with the ethical and
legal framework as well as to provide effective symptom
management. This study might suggest that a greater
integration of palliative medicine with neurology ser-
vices has potential to improve the experiences of all
involved and the outcomes for patient and families.
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